Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord.
[Vitamin D tweets light to genes in multiple sclerosis].
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Carnitine for fatigue in multiple sclerosis.
Birth hospitalization in mothers with multiple sclerosis and their newborns.
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Pathology of Multiple Sclerosis.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.
Pages
« first
‹ previous
…
200
201
202
203
204
205
206
207
208
…
next ›
last »